Upstream Biosciences seeks US patent for ovarian cancer biomarkers (Pharmaceutical Business Review)

Upstream Biosciences seeks US patent for ovarian cancer biomarkers (Pharmaceutical Business Review)
Canadas Upstream Biosciences has filed a US provisional patent application for certain ovarian cancer biomarkers that could be useful for determining whether patients have a genetic risk of developing ovarian cancer.